Next-Generation Tablet Press
The NexGen Press 45 is the latest member of GEA Pharma & Healthcare’s NexGen Press line of tablet presses.
GEA’s NexGen Press line of tablet presses | Image Credit: © GEA Pharma & Healthcare
GEA Pharma & Healthcare has introduced NexGen Press 45, the latest member of its NexGen Press line of tablet presses. The larger NexGen Press 45 builds on the previous NexGen Press 30 version and offers the same benefits as the smaller generation, including flexibility to adapt to any containment level (up to occupational exposure band 5 [OEB5]), which is attributed to the FAST CHANGEOVER Exchangeable Compression Module (FCO ECM). The new press can also be equipped with the same option packs as the previous version, enabling agile production and making it a system that can be tailored to accommodate a wide range of tableting applications (e.g., multi-unit pellet system, bilayer, poorly flowing products, high yield, microtablets, etc.). Additionally, the system can accommodate different cleaning strategies (wash offline or inline). A further advantage of the NexGen Press range is that every machine is equipped with six compression modes and each benefits from GEA’s unique Air Compensator technology, which effectively reduces common compression issues.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
